表紙
市場調査レポート

分子診断の世界市場予測 2020年:PCR・マイクロアレイ・DNAシークエンシング

Molecular Diagnostics Market by Application (Infectious Disease (HIV, HPV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Microarray, DNA Sequencing), End User, Product (Instruments, Reagent, Software) - Forecast to 2020

発行 MarketsandMarkets 商品コード 253279
出版日 ページ情報 英文 259 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
分子診断の世界市場予測 2020年:PCR・マイクロアレイ・DNAシークエンシング Molecular Diagnostics Market by Application (Infectious Disease (HIV, HPV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Microarray, DNA Sequencing), End User, Product (Instruments, Reagent, Software) - Forecast to 2020
出版日: 2015年11月16日 ページ情報: 英文 259 Pages
概要

世界の分子診断市場は、今後9.3%のCAGRで拡大し、2020年までに93億3,380万米ドルに達すると推計されています。同市場の主な促進要因は、感染症および各種癌の高い罹患率、バイオマーカーの開発、および分子技術・プロテオミクスの進歩と医療費償還制度改革です。しかし、分子診断ツールのコスト上昇、新しい・複雑なプラットフォームを扱う熟練労働者の不足、および複雑な規制の枠組みは、分子診断市場の成長を抑制する主な要因となっています。

当レポートでは、世界の分子診断市場を取り上げ、市場の概要、市場発展促進・阻害要因、市場における課題および機会を概括し、用途別・技術別・製品タイプ別・地域別に市場の現状と見通しについて調査分析するとともに、競合環境、主要企業のプロファイルをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 分子診断市場
  • 分子診断市場:感染症
  • 分子診断市場:技術・アプリケーション別
  • 分子診断市場:エンドユーザー別
  • 分子診断市場:製品・サービス別

第5章 市場概要

  • イントロダクション
  • 市場ダイナミクス
    • 市場発展促進要因
    • 市場発展阻害要因
    • 市場機会
    • 課題

第6章 分子診断市場:アプリケーション別

  • イントロダクション
  • 感染症
    • B型肝炎
    • C型肝炎
    • ヒト免疫不全ウイルス (HIV)
    • 結核 (TB)
    • クラミジア・トラコマチスおよび淋菌 (CT/NG)
    • ヒトパピローマウイルス (HPV)
    • メチシリン耐性黄色ブドウ球菌 (MRSA)
    • その他
  • 腫瘍
    • 前立腺がん
    • 乳がん
    • 結腸直腸がん
    • その他
  • 遺伝
  • 血液検査
  • 微生物
  • その他

第7章 分子診断市場:技術別

  • イントロダクション
  • ポリメラーゼ連鎖反応 (PCR)
  • 等温核酸増幅技術 (INAAT)
  • マイクロアレイ
  • ハイブリダイゼーション (in situハイブリダイゼーションおよび蛍光in situハイブリダイゼーション:FISH)
  • DNAシークエンシング・次世代シークエンシング
  • その他の技術

第8章 分子診断市場:製品・サービス別

  • イントロダクション
  • 試薬
  • 器具
  • サービス・ソフトウェア

第9章 分子診断市場:エンドユーザー別

  • イントロダクション
  • 病院/大学ラボ
  • 参考検査室
  • その他のエンドユーザー

第10章 分子診断市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • その他欧州諸国 (ROE)
  • アジア
    • 日本
    • インド
    • 中国
    • その他アジア諸国 (ROA)
  • その他地域 (ROW)
    • ラテンアメリカ
    • 太平洋
    • 中東・アフリカ

第11章 競合環境

  • 概要
  • 市場シェア分析
  • 分子診断市場の競合企業シェア分析:アプリケーション別
  • 分子診断市場の競合企業シェア分析:技術別
  • 製品認可
  • 合意、コラボレーションおよび提携
  • 新製品発売
  • 買収
  • その他の動き

第12章 企業プロファイル

  • イントロダクション
  • ABBOTT LABORATORIES
  • QIAGEN N.V.
  • ROCHE DIAGNOSTICS
  • HOLOGIC, INC.
  • GRIFOLS
  • SIEMENS HEALTHCARE
  • BECTON, DICKINSON AND COMPANY
  • BECKMAN COULTER INC. (WHOLLY OWNED SUBSIDIARY OF DANAHER CORPORATION)
  • BIOMERIEUX SA
  • CEPHEID INC

第13章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 2521

The molecular diagnostics market is estimated to grow at a CAGR of 9.3% to reach USD 9,333.8 million by 2020.

In this report, the molecular diagnostics market is broadly segmented on the basis of technologies, applications, products & services, and end users. On the basis of technology, the market is segmented into PCR, INAAT, microarrays, hybridization, DNA sequencing and next-generation sequencing (NGS), and other technologies. Among these technologies, PCR is expected to command the largest share while microarrays is expected to grow at the highest rate.

The molecular diagnostics market, by application, is classified into infectious diseases, oncology, genetics, blood screening, microbiology, and others (cardiovascular diseases, neurological diseases, DNA fingerprinting, tissue typing, and food pathogen detection testing). The infectious diseases segment will account for the largest share of the global molecular diagnostics market in 2015, followed by the blood screening and oncology segments.

On the basis of products and services, the molecular diagnostics market is segmented into instruments, reagents, and services & software. The reagents segment is expected to account for the largest share and highest CAGR of the molecular diagnostics market in 2015.

Based on end users, the market is segmented into hospital & academic laboratories, reference laboratories, and others (blood banks, local public health laboratories, home health agencies, nursing homes, point-of-care settings, and self-testing). As most diagnostic tests are carried out in-house, the hospital & academic laboratories segment is expected to dominate the market. On the other hand, newly launched, complex, and highly specialized tests are mostly offered only at a few large reference laboratories, owing to which the reference laboratories segment is expected to grow at the highest rate during the forecast period.

The major factors driving this market are high prevalence of infectious diseases and various types of cancer; increasing awareness and acceptance of personalized medicine and companion diagnostics; development of biomarkers; and advancements in molecular techniques, proteomics, and reformations in the reimbursement system. However, increased cost of molecular diagnostics tools, dearth of skilled labor to handle new and complex platforms, and the complex regulatory framework are the major factors restraining the growth of the molecular diagnostics market.

Major players operating in the molecular diagnostics market are Roche Diagnostics (U.S.), QIAGEN N.V. (Netherlands), Hologic Inc. (U.S.), Grifols (Spain), Abbott Laboratories (U.S.), Siemens Healthcare (Germany), Becton, Dickinson and Company (U.S.), Beckman Coulter Inc. (U.S.), bioMerieux SA (France), and Cepheid Inc. (U.S.).

Scope of the report:

This market study majorly covers the products and services, applications, technologies, and end users for arriving at the overall molecular diagnostics market size in the period from 2015 to 2020.

Years Considered for the Study

Market Segmentation

Molecular Diagnostics Market, by Products and Services

  • Instruments
  • Reagents
  • Services & Software

Molecular Diagnostics Market, by Technology

  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Hybridization [In Situ Hybridization & Fluorescent In Situ Hybridization (FISH)]
  • DNA Sequencing and Next-generation Sequencing
  • Microarrays
  • Others (Mass Spectrometry, Flow Cytometry, and Electrophoresis)

Molecular Diagnostics Market, by Application

  • Infectious Diseases
  • Oncology
  • Genetics
  • Blood Screening
  • Microbiology
  • Others (Cardiovascular Diseases, Neurological Diseases, and DNA Fingerprinting)

Molecular Diagnostics Market, by End User

  • Reference Laboratories
  • Hospital Laboratories
  • Others (Blood Banks, Local Public Health Laboratories, Home Health Agencies, Nursing Homes, Point-of-care Settings, and Self-testing)

Molecular Diagnostics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia
    • Japan
    • India
    • China
    • Rest of Asia (RoA)
  • Rest of the World (RoW)
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America (RoLA)
    • Pacific Countries
    • Middle East & Africa

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKETS SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.2.1. KEY DATA FROM SECONDARY SOURCES
    • 2.2.2. KEY DATA FROM PRIMARY SOURCES
      • 2.2.2.1. Key Industry Insights
    • 2.2.3. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. MOLECULAR DIAGNOSTICS MARKET
  • 4.2. MOLECULAR DIAGNOSTICS MARKET,INFECTIOUS DISEASES
  • 4.3. MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY AND APPLICATION
  • 4.4. MOLECULAR DIAGNOSTICS MARKET, BY END USER
  • 4.5. MOLECULAR DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. High prevalence rate of infectious diseases and various types of cancer
      • 5.2.1.2. Increasing awareness and acceptance of personalized medicine and companion diagnostics
      • 5.2.1.3. Development of biomarker identification and advancements in molecular techniques
      • 5.2.1.4. Growth in proteomics and genomics research
      • 5.2.1.5. Reforms in the reimbursement system in the U.S.
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Molecular diagnostic tools with new and complex platforms demand skilled labor and mandatory training
      • 5.2.2.2. Complex regulatory framework to delay approvals of new molecular diagnostic tests
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Advances in genomics
      • 5.2.3.2. Significant growth prospects in developing countries
    • 5.2.4. CHALLENGE
      • 5.2.4.1. Dearth of trained professionals limiting the appropriate use of new molecular diagnostic technologies

6. MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION

  • 6.1. INTRODUCTION
  • 6.2. INFECTIOUS DISEASES
    • 6.2.1. HEPATITIS B
    • 6.2.2. HEPATITIS C
    • 6.2.3. HUMAN IMMUNODEFICIENCY VIRUS (HIV)
    • 6.2.4. TUBERCULOSIS (TB)
    • 6.2.5. CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG)
    • 6.2.6. HUMAN PAPILLOMAVIRUS (HPV)
    • 6.2.7. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA)
    • 6.2.8. OTHERS
  • 6.3. ONCOLOGY
    • 6.3.1. PROSTATE CANCER
    • 6.3.2. BREAST CANCER
    • 6.3.3. COLORECTAL CANCER
    • 6.3.4. OTHERS
  • 6.4. GENETIC TESTS
  • 6.5. BLOOD SCREENING
  • 6.6. MICROBIOLOGY
  • 6.7. OTHERS

7. MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
  • 7.2. POLYMERASE CHAIN REACTION (PCR)
  • 7.3. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT)
  • 7.4. MICROARRAYS
  • 7.5. HYBRIDIZATION (IN-SITU HYBRIDIZATION & FISH)
  • 7.6. DNA SEQUENCING AND NEXT-GENERATION SEQUENCING
  • 7.7. OTHER TECHNOLOGIES

8. MOLECULAR DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES

  • 8.1. INTRODUCTION
  • 8.2. REAGENTS
  • 8.3. INSTRUMENTS
  • 8.4. SOFTWARE & SERVICES

9. MOLECULAR DIAGNOSTICS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. HOSPITAL/ACADEMIC LABORATORIES
  • 9.3. REFERENCE LABORATORIES
  • 9.4. OTHER END USERS

10. MOLECULAR DIAGNOSTIC MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. U.K.
    • 10.3.2. GERMANY
    • 10.3.3. FRANCE
    • 10.3.4. ITALY
    • 10.3.5. SPAIN
    • 10.3.6. REST OF EUROPE (ROE)
  • 10.4. ASIA
    • 10.4.1. JAPAN
    • 10.4.2. INDIA
    • 10.4.3. CHINA
    • 10.4.4. REST OF ASIA (ROA)
  • 10.5. REST OF THE WORLD (ROW)
    • 10.5.1. LATIN AMERICA
      • 10.5.1.1. Mexico
      • 10.5.1.2. Brazil
      • 10.5.1.3. Rest of Latin America (RoLA)
    • 10.5.2. PACIFIC COUNTRIES
    • 10.5.3. MIDDLE EAST & AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET SHARE ANALYSIS
  • 11.3. MOLECULAR DIAGNOSTICS MARKET COMPETITOR SHARE ANALYSIS, BY APPLICATION
    • 11.3.1. MARKET SHARE ANALYSIS FOR INFECTIOUS DISEASE DIAGNOSTICS APPLICATIONS
    • 11.3.2. MARKET SHARE ANALYSIS FOR BLOOD SCREENING APPLICATIONS
    • 11.3.3. MARKET SHARE ANALYSIS FOR MICROBIOLOGY APPLICATIONS
    • 11.3.4. MARKET SHARE ANALYSIS FOR ONCOLOGY APPLICATIONS
    • 11.3.5. MARKET SHARE ANALYSIS FOR GENETIC TESTING
  • 11.4. MOLECULAR DIAGNOSTICS MARKET SHARE ANALYSIS, BY TECHNOLOGY
    • 11.4.1. POLYMERASE CHAIN REACTION (PCR)
    • 11.4.2. DNA SEQUENCING AND NGS
    • 11.4.3. MICROARRAY
    • 11.4.4. HYBRIDIZATION (IN SITU AND FLUORESCENCE)
    • 11.4.5. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT)
  • 11.5. PRODUCT APPROVALS
  • 11.6. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
  • 11.7. NEW PRODUCT LAUNCHES
  • 11.8. ACQUISITIONS
  • 11.9. OTHER DEVELOPMENTS

12. COMPANY PROFILES

  • 12.1. INTRODUCTION
  • 12.2. ABBOTT LABORATORIES
  • 12.3. QIAGEN N.V.
  • 12.4. ROCHE DIAGNOSTICS
  • 12.5. HOLOGIC, INC.
  • 12.6. GRIFOLS
  • 12.7. SIEMENS HEALTHCARE
  • 12.8. BECTON, DICKINSON AND COMPANY
  • 12.9. BECKMAN COULTER INC. (WHOLLY OWNED SUBSIDIARY OF DANAHER CORPORATION)
  • 12.10. BIOMERIEUX SA
  • 12.11. CEPHEID INC.

*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. OTHER DEVELOPMENTS
    • 13.3.1. ABBOTT LABORATORIES
    • 13.3.2. QIAGEN N.V.
    • 13.3.3. ROCHE DIAGNOSTICS
    • 13.3.4. HOLOGIC INC.
    • 13.3.5. HOLOGIC INC.
    • 13.3.6. SIEMENS HEALTHCARE
    • 13.3.7. BECTON, DICKINSON AND COMPANY
    • 13.3.8. BECTON, DICKINSON AND COMPANY
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: HIGH PREVALENCE OF INFECTIOUS DISEASES & CANCER AND GROWTH IN GENOMICS RESEARCH TO DRIVE THE MOLECULAR DIAGNOSTICS MARKET
  • TABLE 2: REQUIREMENT OF HIGHLY SKILLED LABOR AND COMPLEX REGULATORY FRAMEWORK RESTRAINING MARKET GROWTH
  • TABLE 3: DEVELOPING COUNTRIES PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES FOR THE MOLECULAR DIAGNOSTICS MARKET
  • TABLE 4: DEARTH OF TRAINED PROFESSIONALS IS LIMITING THE APPROPRIATE USE OF NEW MOLECULAR DIAGNOSTIC TECHNOLOGIES
  • TABLE 5: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2015-2020 (USD MILLION)
  • TABLE 6: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 7: NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 8: EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 9: ASIA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 10: ROW: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 11: LATIN AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 12: INFECTIOUS DISEASES DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC AREA, 2015-2020 (USD MILLION)
  • TABLE 13: HEPATITIS B DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 14: HEPATITIS B DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 (MILLION ASSAYS)
  • TABLE 15: HEPATITIS C MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 16: HEPATITIS C MARKET SIZE, BY REGION, 2015-2020 (MILLION ASSAYS)
  • TABLE 17: HIV DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 18: HEPATITIS C MARKET SIZE, BY REGION, 2015-2020 (MILLION ASSAYS)
  • TABLE 19: TB DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 20: TB DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 (MILLION ASSAYS)
  • TABLE 21: CT/NG DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 22: CT/NG DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 (MILLION ASSAYS)
  • TABLE 23: HPV DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 24: HPV DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 (MILLION ASSAYS)
  • TABLE 25: MRSA DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 26: MRSA DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 (MILLION ASSAYS)
  • TABLE 27: OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 28: ONCOLOGY DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 29: NORTH AMERICA: ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 30: EUROPE: ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 31: ASIA: ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 32: ROW: ONCOLOGY MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 33: LATIN AMERICA: ONCOLOGY MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 34: ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2015-2020 (USD MILLION)
  • TABLE 35: ONCOLOGY MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2015-2020 (MILLION ASSAYS)
  • TABLE 36: PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 37: BREAST CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 38: COLORECTAL CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 39: OTHER CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 40: GENETIC TESTS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 41: NORTH AMERICA: GENETICS TESTS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 42: EUROPE: GENETIC TESTS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 43: ASIA: GENETIC TESTS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 44: ROW: GENETIC TESTS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 45: LATIN AMERICA: GENETIC TESTS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 46: BLOOD SCREENING MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 47: NORTH AMERICA: BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 48: EUROPE: BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 49: ASIA: BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 50: ROW: BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 51: LATIN AMERICA: BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 52: MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 53: NORTH AMERICA: MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 54: EUROPE: MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 55: ASIA: MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 56: ROW: MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 57: LATIN AMERICA: MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 58: OTHER MOLECULAR DIAGNOSTICS APPLICATIONS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 59: NORTH AMERICA: OTHER MOLECULAR DIAGNOSTICS APPLICATIONS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 60: EUROPE: OTHER MOLECULAR DIAGNOSTICS APPLICATIONS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 61: ASIA: OTHER MOLECULAR DIAGNOSTICS APPLICATIONS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 62: ROW: OTHER MOLECULAR DIAGNOSTICS APPLICATIONS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 63: LATIN AMERICA: OTHER MOLECULAR DIAGNOSTICS APPLICATIONS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 64: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 65: MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 66: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 67: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 68: ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 69: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 70: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 71: MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 72: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 73: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 74: ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 75: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 76: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 77: MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 78: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 79: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 80: ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 81: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 82: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 83: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 84: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 85: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 86: ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 87: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 88: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 89: MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 90: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 91: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 92: ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 93: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 94: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 95: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 96: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 97: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 98: ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 99: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 100: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 101: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCTS & SERVICES, 2015-2020 (USD MILLION)
  • TABLE 102: MOLECULAR DIAGNOSTIC REAGENTS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 103: MOLECULAR DIAGNOSTIC REAGENTS MARKET SIZE, BY TECHNOLOGY, 2015-2020 (USD MILLION)
  • TABLE 104: NORTH AMERICA: MOLECULAR DIAGNOSTIC REAGENTS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 105: EUROPE: MOLECULAR DIAGNOSTIC REAGENTS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 106: ASIA: MOLECULAR DIAGNOSTIC REAGENTS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 107: ROW: MOLECULAR DIAGNOSTIC REAGENTS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 108: LATIN AMERICA: MOLECULAR DIAGNOSTIC REAGENTS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 109: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 110: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2015-2020 (USD MILLION)
  • TABLE 111: NORTH AMERICA: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 112: EUROPE: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 113: ASIA: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 114: ROW: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 115: LATIN AMERICA: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 116: MOLECULAR DIAGNOSTIC SOFTWARE & SERVICES MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 117: NORTH AMERICA: MOLECULAR DIAGNOSTIC SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 118: EUROPE: MOLECULAR DIAGNOSTIC SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 119: ASIA: MOLECULAR DIAGNOSTIC SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 120: ROW: MOLECULAR DIAGNOSTIC SOFTWARE & SERVICES MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 121: LATIN AMERICA: MOLECULAR DIAGNOSTIC SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2015-2020 (USD MILLION)
  • TABLE 122: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 123: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL/ACADEMIC LABORATORIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 124: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL/ACADEMIC LABORATORIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 125: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL/ACADEMIC LABORATORIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 126: ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL/ACADEMIC LABORATORIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 127: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL/ACADEMIC LABORATORIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 128: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL/ACADEMIC LABORATORIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 129: MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 130: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 131: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 132: ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 133: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 134: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 135: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 136: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 137: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 138: ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 139: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 140: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS LABORATORIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 141: MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 142: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 143: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 144: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 145: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 146: U.S.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 147: U.S.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 148: U.S.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 149: U.S.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 150: CANADA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 151: CANADA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 152: CANADA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 153: CANADA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 154: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 155: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 156: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 157: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 158: U.K.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 159: U.K.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 160: U.K.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 161: U.K.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 162: GERMANY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 163: GERMANY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 164: GERMANY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 165: GERMANY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 166: FRANCE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 167: FRANCE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 168: FRANCE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 169: FRANCE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 170: ITALY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 171: ITALY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 172: ITALY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 173: ITALY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 174: SPAIN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 175: SPAIN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 176: SPAIN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 177: SPAIN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 178: ROE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 179: ROE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 180: ROE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 181: ROE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 182: ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 183: ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 184: ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 185: ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 186: JAPAN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 187: JAPAN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 188: JAPAN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 189: JAPAN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 190: INDIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 191: INDIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 192: INDIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 193: INDIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 194: CHINA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 195: CHINA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 196: CHINA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 197: CHINA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 198: ROA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 199: ROA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 200: ROA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 201: ROA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 202: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 203: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 204: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 205: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 206: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 207: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 208: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 209: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 210: MEXICO: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 211: MEXICO: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 212: MEXICO: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 213: MEXICO: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 214: BRAZIL: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 215: BRAZIL: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 216: BRAZIL: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 217: BRAZIL: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 218: ROLA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 219: ROLA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 220: ROLA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 221: ROLA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 222: PACIFIC COUNTRIES: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 223: PACIFIC COUNTRIES: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 224: PACIFIC COUNTRIES: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 225: PACIFIC COUNTRIES: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 226: MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 227: MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 228: MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 229: MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 230: PRODUCT APPROVALS, 2012-2015
  • TABLE 231: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2012-2015
  • TABLE 232: NEW PRODUCT LAUNCHES, 2012-2015
  • TABLE 233: ACQUISITIONS, 2012-2015
  • TABLE 234: OTHER DEVELOPMENTS, 2012-2015

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: MARKET SIZE ESTIMATION AND DATA TRIANGULATION
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MOLECULAR DIAGNOSTICS MARKET SNAPSHOT (2015 VS. 2020)
  • FIGURE 5: REAGENTS TO ACCOUNT FOR THE LARGEST SHARE OF MOLECULAR DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 6: HOSPITAL & ACADEMIC LABORATORIES TO LEAD THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 7: INFECTIOUS DISEASES SEGMENT WILL CONTINUE TO DOMINATE THE MOLECULAR DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 8: MICROARRAY SEGMENT POISED TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 9: PRODUCT APPROVALS IS THE DOMINANT STRATEGY AMONG MARKET PLAYERS
  • FIGURE 10: RISING PREVALENCE OF INFECTIOUS DISEASES & CANCER TO DRIVE MARKET GROWTH
  • FIGURE 11: MRSA WILL BE THE FASTEST-GROWING SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 12: INFECTIOUS DISEASES SEGMENT DOMINATES THE MOLECULAR DIAGNOSTICS MARKET IN 2015
  • FIGURE 13: HOSPITAL & ACADEMIC LABORATORIES TO DOMINATE THE MOLECULAR DIAGNOSTICS MARKET BY 2020
  • FIGURE 14: REAGENTS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 15: MOLECULAR DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND THREATS
  • FIGURE 16: INFECTIOUS DISEASE DIAGNOSTICS, THE LARGEST SEGMENT OF THE MARKET IN 2015
  • FIGURE 17: MRSA DIAGNOSTICS HOLDS HIGHEST GROWTH POTENTIAL IN THE MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES DURING THE FORECAST PERIOD
  • FIGURE 18: NORTH AMERICA WILL CONTINUE TO LEAD IN ONCOLOGY MOLECULAR DIAGNOSTICS MARKET IN FORECAST PERIOD
  • FIGURE 19: EGFR ASSAY SEGMENT (BY VOLUME) WILL GROW AT THE HIGHEST PACE DURING THE FORECAST PERIOD
  • FIGURE 20: NORTH AMERICA WILL CONTINUE TO DOMINATE GENETICS TESTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 21: ASIA IS THE FASTEST-GROWING MARKET FOR OTHER APPLICATIONS
  • FIGURE 22: PCR TO DOMINATE THE MOLECULAR DIAGNOSTIC TECHNOLOGIES MARKET DURING THE FORECAST PERIOD
  • FIGURE 23: NORTH AMERICA TO DOMINATE THE PCR TECHNOLOGY MARKET DURING THE FORECAST PERIOD
  • FIGURE 24: ASIA TO GROW AT HIGHEST RATE FOR THE INAAT TECHNOLOGY MARKET DURING THE FORECAST PERIOD
  • FIGURE 25: NORTH AMERICA TO DOMINATE THE MICROARRAYS MARKET DURING THE FORECAST PERIOD
  • FIGURE 26: NORTH AMERICA TO DOMINATE THE DNA SEQUENCING AND NEXT-GENERATION SEQUENCING MARKET DURING THE FORECAST PERIOD
  • FIGURE 27: NORTH AMERICA TO DOMINATE THE OTHER TECHNOLOGIES MARKET DURING THE FORECAST PERIOD
  • FIGURE 28: REAGENTS TO FORM THE LARGEST SEGMENT OF THE MOLECULAR DIAGNOSTICS MARKET IN 2015
  • FIGURE 29: MOLECULAR DIAGNOSTIC REAGENTS MARKET IN ASIA TO GROW AT HIGHEST RATE IN 2015
  • FIGURE 30: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET IN 2015
  • FIGURE 31: MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET IN ASIA TO GROW AT THE HIGHEST RATE
  • FIGURE 32: HOSPITAL/ACADEMIC LABORATORIES, THE MAJOR END USERS OF THE MOLECULAR DIAGNOSTICS MARKET
  • FIGURE 33: NORTH AMERICA TO CONTINUE TO DOMINATE THE HOSPITAL/ACADEMIC LABORATORIES MARKET DURING THE FORECAST PERIOD
  • FIGURE 34: ASIA: HIGHEST GROWTH POTENTIAL IN THE REFERENCE LABORATORIES END-USER MARKET SEGMENT
  • FIGURE 35: GERMANY IS THE LARGEST AND FASTEST-GROWING MARKET FOR REFERENCE LABORATORIES
  • FIGURE 36: NORTH AMERICA IS EXPECTED TO BE THE LARGEST REGIONAL SEGMENT IN THE MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS
  • FIGURE 37: ASIA-PACIFIC WILL BE THE FASTEST-GROWING REGION IN THE MOLECULAR DIAGNOSTICS MARKET
  • FIGURE 38: ASIAN MARKET FOR MOLECULAR DIAGNOSTICS PRODUCTS SHOWS SIGNIFICANT GROWTH OPPORTUNITIES
  • FIGURE 39: NORTH AMERICA WILL CONTINUE TO LEAD THE GLOBAL MOLECULAR DIAGNOSTICS MARKET IN THE FORECAST PERIOD
  • FIGURE 40: NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 41: PCR TECHNOLOGY SEGMENT WILL CONTINUE TO LEAD THE NORTH AMERICAN MARKET
  • FIGURE 42: MICROARRAY TECHNOLOGY SEGMENT IS GROWING AT THE FASTEST RATE DURING THE FORECAST PERIOD
  • FIGURE 43: REAGENT SEGMENT WILL CONTINUE TO DOMINATE MOLECULAR DIAGNOSTICS MARKET IN ASIA
  • FIGURE 44: HOSPITAL/ACADEMIC LABORATORIES DOMINATE MOLECULAR DIAGNOSTICS END-USER MARKET IN JAPAN
  • FIGURE 45: LATIN AMERICA WILL CONTINUE TO LEAD THE MOLECULAR DIAGNOSTICS MARKET IN ROW
  • FIGURE 46: INFECTIOUS DISEASE WILL BE THE LARGEST APPLICATION SEGMENT OF THE MOLECULAR DIAGNOSTICS MARKET IN ROW
  • FIGURE 47: BRAZIL TO COMMAND LARGEST SHARE OF LATIN AMERICAN MOLECULAR DIAGNOSTICS MARKET IN 2015
  • FIGURE 48: PRODUCT INNOVATION AND AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS WERE KEY STRATEGIES ADOPTED IN THE LAST THREE YEARS
  • FIGURE 49: GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 50: GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 51: GLOBAL BLOOD SCREENING MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 52: GLOBAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 53: GLOBAL ONCOLOGY MDX DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 54: GLOBAL GENETIC TESTING MDX DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 55: GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR PCR, MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014 (%)
  • FIGURE 56: GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING AND NGS, MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014 (%)
  • FIGURE 57: GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR MICROARRAY, MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014 (%)
  • FIGURE 58: GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR HYBRIDIZATION, MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014 (%)
  • FIGURE 59: GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR INAAT, MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014 (%)
  • FIGURE 60: BATTLE FOR MARKET SHARE: PRODUCT APPROVALS AND AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS WERE KEY STRATEGIES
  • FIGURE 61: GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS
  • FIGURE 62: ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
  • FIGURE 63: HOLOGIC, INC.: COMPANY SNAPSHOT
  • FIGURE 64: GRIFOLS: COMPANY SNAPSHOT
  • FIGURE 65: SIEMENS HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 66: BIOMERIEUX: COMPANY SNAPSHOT 235  
Back to Top